Market Tracker

06/24 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.39
Delayed Data
As of Jun 24
 +0.01 / +0.72%
Today’s Change
1.23
Today|||52-Week Range
2.66
-28.35%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.38
Today’s open1.36
Day’s range1.36 - 1.48
Volume13,832
Average volume (3 months)33,396
Market cap$53.3M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)+59.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd-0.03-0.65%
TNXPTonix Pharmaceutical...-0.10-4.65%
NVETNexvet Biopharma plc-0.01-0.21%
CASICASI Pharmaceuticals...-0.08-6.50%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts